: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214)...